New simple urine and fluid test could transform womb cancer diagnosis
Researchers have developed a new diagnostic test using urine and vaginal fluid samples to detect womb cancer. This non-invasive method could significantly reduce the need for uncomfortable and costly hospital procedures for women experiencing postmenopausal bleeding.
Why it matters
It offers a more efficient, patient-friendly screening process that could improve early detection rates and reduce the burden on healthcare systems.
The approach has the potential to ‘transform care’ for thousands of women each year, researchers said (Getty/iStock) A simple test that looks at cells in urine and vaginal fluid could help rule out womb cancer in women who experience bleeding after menopause.
The approach has the potential to "transform care" for thousands of women each year, researchers said, and could spare patients from "invasive, uncomfortable" tests that can be costly for the health service.
Around 10,200 women are diagnosed with womb cancer – also known as uterine or endometrial cancers – in the UK each year.
Bleeding after the menopause is a common symptom and would trigger an urgent cancer referral.
Tests include ultrasounds, biopsies of the womb lining, and a hysteroscopy, where a camera is passed into the womb.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in